Hyderabad, India (PressExposure) October 25, 2012 -- Acceliant, a global technology provider of innovative clinical solutions, will participate in DIA India's 7th Annual Conference, scheduled for Nov. 1-4, 2012 at the Hyderabad International Convention Center, Novotel & HICC Complex, Hyderabad.
Acceliant invites all the conference attendees to visit Booth # 1, where it will showcase the integration of EDC and e-PRO modules.
"Acceliant is expanding the frontiers of eClinical trial technologies by delivering end-to-end clinical trial solutions. Capturing and reporting of precise data is very important for effective medical monitoring. Acceliant has developed a superior solution which provides an integrated access to e-PRO data within the EDC platform, thereby eliminating integration costs. We will showcase our proprietary solutions at the conference for clinical research organizations, pharmaceutical and biotech firms, having explicit interest in our products and services." said Ven Thangaraj, CTO of Acceliant.
Sri Manchala, President and CEO of Acceliant said, "The conference which is one of its kind addresses the approach to clinical development in this era of healthcare reforms. We are glad and look forward to support the DIA India conference, which provides a platform for knowledge exchange to raise the standards of healthcare worldwide. The conference will help us showcase our eClinical trial technologies and target a vast group of decision makers reducing the time to market."
Acceliant eClinical Suite
Acceliant eClinical Suite is competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 11-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.